Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CAI:NIPH'
s Net Margin % Range Over the Past 10 Years
Min: 7.9 Med: 8.83 Max: 10.72
Current: 10.72
CAI:NIPH's Net Margin % is ranked better than 66.11% of 962
companies
in the Drug Manufacturers industry
Industry Median: 5.56
vs CAI:NIPH: 10.72
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Net Margin % Related Terms
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Net Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Net Margin % Chart
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Annual Data
Trend
Jun24
Jun25
Net Margin %
7.90
9.75
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Quarterly Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Net Margin % vs Drug Manufacturers Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH) has a Net Margin % of 10.81% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile and its competitors. This is 22% above median its historical median of 8.83. Over the past decade, El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Net Margin % has ranged from 7.90 to 10.72. According to the industry distribution chart, El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile ranks #326 out of 962 companies in the Drug Manufacturers industry, placing it in the top 33.9%.
Is El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Net Margin % too high?
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's current Net Margin % of 10.81% is 22% above median its 10-year median of 8.83. Over the past 10 years, this metric has ranged from a low of 7.90 to a high of 10.72. The Drug Manufacturers industry median Net Margin % is 5.56. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's value of 10.81% is 94.4% above this industry median. Based on the distribution chart, El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile ranks #326 out of 962 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's Net Margin % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile ranks #326 out of 962 companies for Net Margin %. This puts El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile in the upper half of its industry. The industry median Net Margin % is 5.56. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's value of 10.81% is 94.4% above this benchmark. Historically, El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's own Net Margin % has ranged from 7.90 to 10.72 over the past decade. While the company's 10-year median is 8.83 vs. the industry median of 5.56, El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Drug Manufacturers company?
The median Net Margin % among Drug Manufacturers companies is 5.56, based on 962 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's current Net Margin % of 10.81% is 94.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.56 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's current Net Margin % is 10.81%, which is 22% above median its own 10-year median of 8.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile stock overvalued right now?
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH) has a current Net Margin % of 10.81%. The current Net Margin % is 10.81%, which is 22% above median its 10-year median of 8.83 and 94.4% above the Drug Manufacturers industry median of 5.56. El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile's overall GF Score™ is 28/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile (CAI:NIPH), the current Net Margin % is 10.81% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile Business Description
El-Nile Co For Pharmaceuticals And Chemical Industries - ElNile manufactures and markets pharmaceuticals, medicinal materials, chemical products and surgical threads and medical solutions.
28GF Score
Get the complete analysis for CAI:NIPH
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CAI:NIPH has been successfully added to your 
